Progress of Research on Radiotherapy Combined with Immunotherapy for Brain Metastases from Non-small Cell Lung Cancer / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 705-709, 2023.
Article
em Zh
| WPRIM
| ID: wpr-985865
Biblioteca responsável:
WPRO
ABSTRACT
Lung cancer is the second most common cancer worldwide, and 40% of patients with non-small cell lung cancer may develop brain metastases. Radiotherapy is a classic treatment for brain metastases, and immunotherapy has emerged for advanced non-small cell lung cancer. This article discusses the theoretical bases, clinical efficacy and safety, and the optimum timing of radiotherapy combined with immunotherapy for brain metastases from non-small cell lung cancer to provide reference for clinical practice and scientific research.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Cancer Research on Prevention and Treatment
Ano de publicação:
2023
Tipo de documento:
Article